TipRanks
Advertisement
Advertisement
Gentian Diagnostics Sacrifices Profit on Impairment as U.S. Growth and fCAL Turbo Offset Timing Hit
PremiumCompany AnnouncementsGentian Diagnostics Sacrifices Profit on Impairment as U.S. Growth and fCAL Turbo Offset Timing Hit
5M ago
Gentian Diagnostics Shares Trade Ex-Dividend Ahead of May Payout
Premium
Company Announcements
Gentian Diagnostics Shares Trade Ex-Dividend Ahead of May Payout
5M ago
Gentian Diagnostics Shareholders Approve All Items at 2026 AGM
Premium
Company Announcements
Gentian Diagnostics Shareholders Approve All Items at 2026 AGM
5M ago
Gentian Diagnostics Publishes 2025 Annual Report
PremiumCompany AnnouncementsGentian Diagnostics Publishes 2025 Annual Report
7M ago
Gentian Executives Boost Stakes in Employee Share Purchase Round
Premium
Company Announcements
Gentian Executives Boost Stakes in Employee Share Purchase Round
7M ago
Gentian CTO Increases Stake with Insider Share Purchase
Premium
Company Announcements
Gentian CTO Increases Stake with Insider Share Purchase
8M ago
Gentian Diagnostics Hosts Expert Webinar on NT-proBNP and Heart Failure Diagnostics
PremiumCompany AnnouncementsGentian Diagnostics Hosts Expert Webinar on NT-proBNP and Heart Failure Diagnostics
8M ago
Gentian Diagnostics Strikes Exclusive Global Partnership for New Clinical Chemistry Assay
Premium
Company Announcements
Gentian Diagnostics Strikes Exclusive Global Partnership for New Clinical Chemistry Assay
9M ago
Gentian Diagnostics Refines Key NT-proBNP Assay, Confirms 2026 CE-Marked Launch Target
Premium
Company Announcements
Gentian Diagnostics Refines Key NT-proBNP Assay, Confirms 2026 CE-Marked Launch Target
10M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―